Table 2. Association of iron deficiency and restless legs syndrome.
CSF, cerebrospinal fluid; RLS, restless legs syndrome; IRLSSG, International Restless Legs Syndrome Study Group; PSG, polysomnography; FCM, ferric carboxymaltose; TSAT, transferrin saturation; ICSD-3, International Classification of Sleep Disorders, 3rd edn.; PLMD, periodic limb movement disorder; IV, intravenous; LMWID, low-molecular-weight iron dextran; HMWID, high-molecular-weight iron dextran; IDA, iron deficiency anemia
Study | Sample size | Type of study | Population characteristics | Iron markers assessed | RLS severity measure | Main outcome | Iron supplementation | P- value |
O'Keeffe et al. [9] | 18 | Case-control | Elderly patients with RLS | Serum ferritin, serum iron, vitamin B12, folate, and hemoglobin | IRLSSG Rating Scale [50] | Lower ferritin levels were associated with more severe RLS symptoms. ID, with or without anemia, significantly affects RLS development among elderly patients. | Oral iron (ferrous sulfate) | <0.05 |
Sun et al. [10] | 27 | Retrospective observational with blinded procedures | Adult patients (aged 29-81 years) with RLS | Serum ferritin | Clinical ratings and PSG measures | Lower ferritin levels correlated with greater RLS severity and reduced sleep efficiency | Not studied | N/A |
Earley et al. [11] | 24 | Observational | 16 RLS patients, 8 healthy individuals | CSF ferritin and transferrin, serum iron, ferritin, and transferrin | Clinical ratings and PSG measures | RLS patients had significantly lower CSF ferritin and higher CSF transferrin levels compared to controls, while no significant differences were observed in serum markers. | Not studied | <0.001 |
Trenkwalder et al. [27] | 110 | Randomized clinical trial | Patients with RLS nonanemic but iron-deficient | Serum ferritin, TSAT | IRLSSG Rating Scale [50] | FCM treatment significantly increased serum ferritin and TSAT levels compared to placebo. No correlation was found between baseline serum ferritin levels or changes in iron parameters and improvements in RLS symptoms. | IV FCM | <0.001 |
Cielo et al. [42] | 167 | Observational | Children aged 5-12 years with a history of prematurity | Serum ferritin | ICSD-3 and PSG measures [51] | Higher prevalence of RLS in preterm children | Not studied | <0.001 |
Allen et al. [12] | 31 | Systematic review/guideline formulation | Adults and children with RLS or PLMD | Serum ferritin, TSAT | IRLSSG Rating Scale [50] | Oral iron is the first-line treatment. IV iron should be considered when serum ferritin levels are too high for effective oral absorption or when oral iron is not tolerated or contraindicated. | Oral options include ferrous sulfate combined with vitamin C, while IV options include FCM, iron sucrose, low molecular weight iron dextran (LMWID), iron gluconate, high molecular weight iron dextran (HMWID), ferumoxytol, and iron isomaltoside. | N/A |
Rosen et al. [49] | 47 | Cohort | Pediatric patients aged 5-18 years with RLS | Serum ferritin | Pediatric IRLSSG Rating Scale [52] | A modest, yet nonsignificant, improvement was observed in children with RLS symptoms, despite a significant increase in ferritin levels. | Oral iron (ferrous sulfate + vitamin C) | >0.05 |
Macher et al. (2020) [48] | 176 | Randomized clinical trial | Iron-deficient blood donors | Ferritin, TSAT, hemoglobin | IRLSSG Rating Scale [50] | A significant improvement in RLS symptoms between baseline and after IV or oral iron was seen. IV iron is more effective than oral. | IV (FCM) vs. oral iron (iron fumarate) | <0.001 |
Bae et al. [46] | 124 | Observational cohort study with a case-control comparison | Adults with IDA and RLS | Ferritin, TSAT, hemoglobin, iron, total iron binding capacity | IRLSSG Rating Scale [50] | There is a high prevalence of RLS among patients with IDA, with the majority displaying severe to very severe symptoms. | Not studied | <0.001 |